雷公藤甲素逆转胶质瘤细胞对辅助性T细胞的抑制并下调IFN-γ诱导的PD-L1表达
该研究探讨雷公藤甲素对胶质瘤细胞抑制T细胞的影响。方法为将标记的T细胞与经IFN-γ和雷公藤甲素处理的胶质瘤细胞共培养,用流式细胞术检测T细胞抑制及亚型,并检测六种胶质瘤细胞系PD-L1表达。结果显示雷公藤甲素可逆转T细胞抑制(尤其CD4+ T细胞),诱导IFN-γ和IL-2分泌,克服IL-10抑制,并下调IFN-γ诱导的PD-L1表面表达。结论提示雷公藤甲素可能逆转胶质瘤细胞导致的CD4+ T细胞抑制,并作为靶向PD-L1的候选药物。
要点
- 雷公藤甲素可逆转胶质瘤细胞对CD4+ T细胞的抑制。
- 雷公藤甲素诱导IFN-γ和IL-2分泌,克服IL-10抑制。
- 雷公藤甲素下调IFN-γ诱导的胶质瘤细胞PD-L1表面表达。
核心结论
- 雷公藤甲素可能逆转胶质瘤细胞导致的CD4+ T细胞抑制,并作为靶向PD-L1的候选药物用于胶质瘤治疗。
研究设计与样本
- 研究将标记的T细胞与经IFN-γ和雷公藤甲素处理的胶质瘤细胞共培养,用流式细胞术检测T细胞抑制及亚型,并检测六种胶质瘤细胞系PD-L1表达。
主要发现
- 雷公藤甲素可逆转T细胞抑制,尤其是CD4+ T细胞,并诱导IFN-γ分泌。
- 雷公藤甲素可诱导IL-2分泌,并克服IFN-γ处理条件下胶质瘤细胞引起的IL-10抑制。
- 雷公藤甲素可下调胶质瘤细胞中IFN-γ诱导的PD-L1表面表达。
临床怎么用
- 雷公藤甲素可能作为免疫调节剂,用于逆转胶质瘤微环境中的T细胞抑制并靶向PD-L1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Immunosuppression is one of hallmark features in many cancers including glioma. Triptolide, a natural compound purified from the Chinese herb Tripterygium wilfordii, has been reported to inhibit PD-L1 otherwise known as the B7 homolog 1 (B7-H1) expression in breast cancer. The purpose of this paper is to test the effects of Triptolide on T cell inhibition in glioma cells. METHODS: We labeled T cells and cocultured with Interferon-γ (IFN-γ) and Triptolide treated glioma cells. The effect on inhibition of T cells as well as subtypes of T cells was measured by Flow Cytometry. We also tested the expression of PD-L1 in six glioma cell lines. RESULTS: We found that Triptolide could reverse T cell inhibition especially CD4+ T cell and induced IFN-γ secretion. In addition, Triptolide could also induce interleukin-2 secretion and overcome interleukin-10 inhibition caused by glioma cells under IFN-γ treated condition. Triptolide could also down-regulate IFN-γ induced PD-L1 surface expression in glioma cells. CONCLUSIONS: These results suggest that Triptolide may be used to reverse CD4+ T cell inhibition caused by glioma cells and is an alternative candidate for targeting PD-L1, one of the checkpoint inhibitors for the treatment of glioma.
引用
- Zhang L, Yu JS. Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines. J Neurooncol. 2019. PMID: 31152305. doi:10.1007/s11060-019-03193-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。